DY
Dowling & Yahnke’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $992K | Sell |
3,717
-401
| -10% | -$107K | 0.05% | 223 |
|
|
2022
Q2 | $840K | Sell |
4,118
-924
| -18% | -$188K | 0.04% | 230 |
|
|
2022
Q1 | $1.06M | Sell |
5,042
-963
| -16% | -$203K | 0.05% | 224 |
|
|
2021
Q4 | $1.44M | Sell |
6,005
-559
| -9% | -$134K | 0.07% | 196 |
|
|
2021
Q3 | $1.86M | Sell |
6,564
-290
| -4% | -$82.1K | 0.1% | 171 |
|
|
2021
Q2 | $2.37M | Sell |
6,854
-51
| -0.7% | -$17.7K | 0.14% | 156 |
|
|
2021
Q1 | $1.93M | Sell |
6,905
-170
| -2% | -$47.6K | 0.13% | 157 |
|
|
2020
Q4 | $1.73M | Sell |
7,075
-222
| -3% | -$54.3K | 0.12% | 158 |
|
|
2020
Q3 | $2.07M | Sell |
7,297
-110
| -1% | -$31.2K | 0.17% | 139 |
|
|
2020
Q2 | $1.98M | Sell |
7,407
-75
| -1% | -$20.1K | 0.17% | 136 |
|
|
2020
Q1 | $2.37M | Buy |
7,482
+97
| +1% | +$30.7K | 0.23% | 116 |
|
|
2019
Q4 | $2.19M | Buy |
7,385
+338
| +5% | +$100K | 0.17% | 138 |
|
|
2019
Q3 | $1.64M | Sell |
7,047
-131
| -2% | -$30.5K | 0.14% | 160 |
|
|
2019
Q2 | $1.68M | Sell |
7,178
-1,413
| -16% | -$331K | 0.14% | 156 |
|
|
2019
Q1 | $2.03M | Buy |
8,591
+592
| +7% | +$140K | 0.2% | 122 |
|
|
2018
Q4 | $2.67M | Buy |
7,999
+97
| +1% | +$32.4K | 0.28% | 98 |
|
|
2018
Q3 | $2.79M | Buy |
7,902
+3
| +0% | +$1.06K | 0.24% | 113 |
|
|
2018
Q2 | $2.29M | Buy |
7,899
+406
| +5% | +$118K | 0.21% | 128 |
|
|
2018
Q1 | $2.05M | Buy |
7,493
+178
| +2% | +$48.7K | 0.19% | 137 |
|
|
2017
Q4 | $2.33M | Buy |
7,315
+133
| +2% | +$42.4K | 0.21% | 129 |
|
|
2017
Q3 | $2.25M | Buy |
7,182
+347
| +5% | +$109K | 0.23% | 123 |
|
|
2017
Q2 | $1.86M | Sell |
6,835
-67
| -1% | -$18.2K | 0.2% | 136 |
|
|
2017
Q1 | $1.89M | Buy |
6,902
+273
| +4% | +$74.6K | 0.2% | 136 |
|
|
2016
Q4 | $1.88M | Buy |
6,629
+168
| +3% | +$47.6K | 0.21% | 126 |
|
|
2016
Q3 | $2.02M | Buy |
6,461
+450
| +7% | +$141K | 0.24% | 122 |
|
|
2016
Q2 | $1.45M | Buy |
6,011
+850
| +16% | +$206K | 0.17% | 140 |
|
|
2016
Q1 | $1.34M | Buy |
5,161
+361
| +8% | +$94K | 0.17% | 143 |
|
|
2015
Q4 | $1.47M | Buy |
4,800
+196
| +4% | +$60K | 0.18% | 131 |
|
|
2015
Q3 | $1.34M | Buy |
4,604
+1,336
| +41% | +$390K | 0.18% | 134 |
|
|
2015
Q2 | $1.32M | Buy |
3,268
+195
| +6% | +$78.8K | 0.17% | 137 |
|
|
2015
Q1 | $1.3M | Buy |
3,073
+4
| +0.1% | +$1.69K | 0.16% | 137 |
|
|
2014
Q4 | $1.04M | Buy |
3,069
+220
| +8% | +$74.7K | 0.13% | 150 |
|
|
2014
Q3 | $942K | Buy |
2,849
+92
| +3% | +$30.4K | 0.12% | 149 |
|
|
2014
Q2 | $869K | Buy |
2,757
+138
| +5% | +$43.5K | 0.11% | 157 |
|
|
2014
Q1 | $801K | Buy |
2,619
+234
| +10% | +$71.6K | 0.11% | 159 |
|
|
2013
Q4 | $667K | Sell |
2,385
-75
| -3% | -$21K | 0.09% | 168 |
|
|
2013
Q3 | $592K | Buy |
2,460
+176
| +8% | +$42.4K | 0.09% | 168 |
|
|
2013
Q2 | $492K | Buy |
+2,284
| New | +$492K | 0.08% | 172 |
|